リスク警告: 当社の製品はレバレッジを使用しており、高いリスクが伴います。投資元本全額を失う可能性もあります。そのような製品はすべての投資家に適しているとは限りません。関連するリスクを十分に理解することが極めて重要です。
  • サポート
  • 機関投資家向け
リスク警告: 当社の製品はレバレッジを使用しており、高いリスクが伴います。投資元本全額を失う可能性もあります。そのような製品はすべての投資家に適しているとは限りません。関連するリスクを十分に理解することが極めて重要です。
  • サポート
  • 機関投資家向け

Current region:

  • 日本語
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese
リスク警告: 当社の製品はレバレッジを使用しており、高いリスクが伴います。投資元本全額を失う可能性もあります。そのような製品はすべての投資家に適しているとは限りません。関連するリスクを十分に理解することが極めて重要です。
リスク警告:レバレッジ商品は高いリスクを伴い、投資元本をすべて失う可能性があります。投資を行う前に、リスクを十分に理解してください。
リスク警告:レバレッジ商品は高いリスクを伴い、投資元本をすべて失う可能性があります。投資を行う前に、リスクを十分に理解してください。

Current region:

  • 日本語
    ACTIVE
Other languages:
  • Español – Spanish
  • Português – Portuguese
  • English – International
  • 日本語 – Japanese

Today’s stocks to watch: GE Vernova, Tesla, and SAP

Key Points To Watch Out For:

  • GE Vernova shares jumped more than 7% after reporting surprise earnings
  • Tesla rose after weak results and comments from Elon Musk
  • SAP soared 10% after exceeding expectations and maintaining its annual forecast

GE Vernova (GEV): Strong rebound with earnings and order growth

GE Vernova rose more than 7% in premarket trading after reported quarterly earnings, driven by a sharp increase in orders and revenue. GE’s energy division, which focuses on natural gas turbines, is making a robust recovery in its move to become an independent company.

Tesla (TSLA): Positive reaction despite disappointing results

Tesla shares rose in premarket trading, despite quarterly earnings that were below expectaions. Investors reacted favorably to statements by Elon Musk, who said he would devote less time to his role in the Trump administration, easing market concerns about potential executive distractions.

SAP (SAP): Solid results dispel trade fears

SAP jumped 10% in Germany after reporting quarterly earnings and revenue above consensus estimates. In addition, the company mantained its guidance for the year, sending a vote of confidence amid concerns about tariffs and global operating costs.

Boeing (BA): Expectations for results and recovery plan

Boeing rose nearly 2% before the open, ahead of its earnings report, which will reveal progress (or setbacks) in its strategy to cut costs and secure extra financing. The company remains in the spotlight due to regulatory and operational issues.

Bristol Myers Squibb (BMY): Drop after key clinical trial failure

Bristol Myers fell 4% in premarket trading after its schizophrenia treatment, Cobenfy, failed to achieve the objectives of a clinical trial. The drug was one of the most eagerly awaited in its development pipeline.

Reckitt Benckiser (UK:RKT): Delays and tariffs affect confidence

Reckitt fell 4% in London after saying that market conditions could delay the sale of some household product brands. The company also cautioned about the potential cost impact of tariffs, although it is confident in its capacity to offset them.

Oklo (OKLO): Altman steps down as chairman amid strategic speculation

Oklo shares fell 1.5% in premarket trading after it was announced that Sam Altman, CEO of OpenAI, will step down as chairman of the nuclear startup. While the news sparked specification about possible deals between the two firms, the stock market took a cautious approach after Monday’s strong rally.

Related posts

AUD Steady Despite China Trade Beat

AUD Steady Despite China Trade Beat

The Australian Dolla […]

Technical Analysis-EN

EURUSD Awaits ECB Rate Decision

The European Central […]

Featured-WeeklyOutlook-EN (1)

Weekly Market Outlook | 8–12 June

Global markets enter […]